下載

D-U-N-S® Certified Profile

Issued Date: 2021/11/15
Validity Date: 2024/11/14
Business Basic Informationcheckbox imgVerified by D&B
D-U-N-S® Number 65-674-0792
Business Registration No. 86649884
Company Name GENEMAX MEDICAL PRODUCTS INDUSTRY CORP.
Company Type a private company limited by shares
Company Operating Address No. 86, Lane 226, Tai-Ming Rd., Wuri Dist., Taichung City, Taiwan
Phone
+886-4-23358500
Fax
+886-4-23356780
Email Contact Us
Company Website www.genemax.com.tw
Taiwantrade Website of Company genemax886.en.taiwantrade.com
Line of Business Wholesale of Other Machinery and Equipment | Wholesale of General Merchandise | Manufacture of Other Medical Instruments and Supplies | Manufacturer of wheelchairs, power wheelchairs, home care beds, walkers, scooters
Main Products Rollator
Wheelchair
Scooter
Medical bed
Homecare series products
Brand Name Genemax
SIC Code
50840000, 50990000, 38410000, 38410500
Employee Here 20~49
Employee Total 20~49
About Companycheckbox imgProvided by Customer
Genemax Medical Products Industry Corp. was founded by Mr. Richard Sung in 1992. We design and manufacture wheelchairs, home beds, rollators, mobility scooter, commode chairs and home care series.The company’s products including medical supplies & hospital equipment- medical products, power wheelchair, hospital beds, medical home beds, walkers, rollator & delta walkers, shower benches, rehabilitation equipment, commode chairs, I.V pole & oxygen tank carts, pedal exercisers, knee scooters, comfort support chairs, home care and so on.
Business Registration Informationcheckbox imgVerified by D&B
Registration Date 1992/05/08
Authorized Capital TWD 7,020,000
Paid Up Capital TWD 7,020,000
Registration Address No. 198, Wuquan 5th St.
Name of Representative Song, Zhong Zhe
Registraction Authority Taichung City Government
Management Informationcheckbox imgVerified by D&B
Name Jobtitle On board date
Sung, Chung Che President
Sung, Chun Ming General Manager
R&D Capability and Production Capabilitycheckbox imgProvided by Customer
No. of R&D staff 5
R&D Expense to Revenue Ratio in the Most Recent Years